These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 37337194)

  • 1. Evidence for causal effects of polycystic ovary syndrome on oxidative stress: a two-sample mendelian randomisation study.
    Yifu P
    BMC Med Genomics; 2023 Jun; 16(1):141. PubMed ID: 37337194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
    Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
    Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
    Jiang X; Deng Q; Stener-Victorin E
    Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.
    Guo X; Chen L; He J; Zhang X; Xu S
    BMC Womens Health; 2024 Jun; 24(1):357. PubMed ID: 38902677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.
    Zhao Y; Xu Y; Wang X; Xu L; Chen J; Gao C; Wu C; Pan D; Zhang Q; Zhou J; Chen R; Wang Z; Zhao H; You L; Cao Y; Li Z; Shi Y
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32163573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
    Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
    Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
    Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
    Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
    [No Abstract]   [Full Text] [Related]  

  • 8. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study.
    Ma Y; Cai J; Liu LW; Hou W; Wei Z; Wang Y; Xu Y
    Int J Gynaecol Obstet; 2023 Sep; 162(3):1050-1056. PubMed ID: 37128830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal relationships exist between polycystic ovary syndrome and adverse pregnancy and perinatal outcomes: a Mendelian randomization study.
    Ma Y; Cai J; Liu LW; Wen T; Huang W; Hou W; Wei Z; Xu Y; Xu Y; Wang Y; Mai Q
    Front Endocrinol (Lausanne); 2024; 15():1327849. PubMed ID: 39006363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study.
    Simons PIHG; Cornelissen MEB; Valkenburg O; Onland-Moret NC; van der Schouw YT; Stehouwer CDA; Burgess S; Brouwers MCGJ
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):599-604. PubMed ID: 34524719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
    Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
    Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.
    Chen S; Guo Z; Yu Q
    Hum Genomics; 2023 Nov; 17(1):100. PubMed ID: 37957681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional Mendelian randomization study.
    Wang J; Fiori PL; Capobianco G; Carru C; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1275419. PubMed ID: 38318294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is thyroid function associated with polycystic ovary syndrome? A bidirectional Mendelian randomization study.
    Zhang Q; Ke W; Ye J; Zhang P; Yang Q; Pan F; Wang K; Zha B
    Endocrine; 2024 Jul; 85(1):380-391. PubMed ID: 38472621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic insights of blood lipid metabolites on polycystic ovary syndrome risk: a bidirectional two-sample Mendelian randomization study.
    Wang X; Han H; Shi X; Nie X; Zhu R; Jin J; Zhou H
    Front Endocrinol (Lausanne); 2024; 15():1391826. PubMed ID: 39045272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically predicted serum testosterone and risk of gynecological disorders: a Mendelian randomization study.
    Zhao B; Wang Z; Liu D; Zhang S
    Front Endocrinol (Lausanne); 2023; 14():1161356. PubMed ID: 38075074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome.
    Sun Y; Li S; Liu H; Bai H; Hu K; Zhang R; Liu Q; Fan P
    Fertil Steril; 2021 Dec; 116(6):1641-1650. PubMed ID: 34433519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of obstructive sleep apnea syndrome with polycystic ovary syndrome through bidirectional Mendelian randomization.
    Liu P; Zhang Q; Ding H; Zou H
    Front Med (Lausanne); 2024; 11():1429783. PubMed ID: 39005659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study.
    Zhang X; Huangfu Z; Wang S
    Endocrine; 2023 Dec; 82(3):695-706. PubMed ID: 37668928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.